Market closed
Inotiv/$NOTV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Inotiv
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
Ticker
$NOTV
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
2,026
Website
Inotiv Metrics
BasicAdvanced
$99M
-
-$4.60
3.59
-
Price and volume
Market cap
$99M
Beta
3.59
52-week high
$11.42
52-week low
$1.23
Average daily volume
727K
Financial strength
Current ratio
1.571
Quick ratio
0.991
Long term debt to equity
255.88
Total debt to equity
263.265
Interest coverage (TTM)
-1.23%
Management effectiveness
Return on assets (TTM)
-4.71%
Return on equity (TTM)
-56.93%
Valuation
Price to revenue (TTM)
0.161
Price to book
0.58
Price to tangible book (TTM)
-0.52
Price to free cash flow (TTM)
-2.943
Growth
Revenue change (TTM)
-18.81%
Earnings per share change (TTM)
255.03%
3-year revenue growth (CAGR)
44.97%
3-year earnings per share growth (CAGR)
-3.34%
What the Analysts think about Inotiv
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Inotiv stock.
Inotiv Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Inotiv Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Inotiv News
AllArticlesVideos
Inotiv, Inc. (NOTV) Q1 2025 Earnings Call Transcript
Seeking Alpha·1 month ago
Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025
GlobeNewsWire·2 months ago
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Inotiv stock?
Inotiv (NOTV) has a market cap of $99M as of March 14, 2025.
What is the P/E ratio for Inotiv stock?
The price to earnings (P/E) ratio for Inotiv (NOTV) stock is 0 as of March 14, 2025.
Does Inotiv stock pay dividends?
No, Inotiv (NOTV) stock does not pay dividends to its shareholders as of March 14, 2025.
When is the next Inotiv dividend payment date?
Inotiv (NOTV) stock does not pay dividends to its shareholders.
What is the beta indicator for Inotiv?
Inotiv (NOTV) has a beta rating of 3.59. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.